Johnson & Johnson MedTech has received FDA 510(k) clearance for its Dualto Energy System, a cutting-edge electrosurgical platform that simplifies workflows in operating rooms and integrates with the company’s Ottava robotic system.
The Dualto system combines energy modalities from two of J&J’s previous-generation systems: the Megadyne Electrosurgical Generator (monopolar and bipolar) and the Endo-Surgery Generator Gen11 (ultrasonic and advanced bipolar). This modular design allows it to power multiple tools simultaneously, offering clinicians greater flexibility during complex surgeries.
Sandeep Makkar, J&J MedTech’s Worldwide President of Endomechanical & Energy, explained that the Dualto system reduces the footprint of traditional surgical equipment by 46%, cutting down on clutter and minimizing electrical interference in the operating room. The system is also designed to be adaptable for various clinical environments, whether in long-duration hospital procedures or shorter outpatient surgeries in ambulatory surgical centers (ASCs).
The platform’s user-friendly interface allows for quick customization, with the ability to save and retrieve pre-configured settings tailored to specific procedures. This is particularly useful in operating rooms where staff turnover is common, reducing the stress of unfamiliar settings for new team members.
The system’s advanced computing capabilities allow it to monitor and adjust energy delivery in real time based on tissue characteristics, ensuring precise cuts and seals during surgery. This dynamic tissue sensing is powered by modern microelectronics and field-programmable gate arrays (FPGAs), which provide the processing speed necessary for accurate tissue responses.
Additionally, the Dualto system integrates with J&J’s Polyphonic Fleet digital management system, enabling remote diagnostics and real-time monitoring of device performance in the operating room.
Currently in a limited launch phase, the Dualto Energy System has received positive feedback, and a full market release is planned for later this year.
Related topics: